CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 7 enrolled / 7 target
Drug / intervention
Virtual realitydevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06139016
NCT06139016N/ACompletedOn Track (0.3/mo)Completion was 19mo ago
CompareCT.gov

Using Virtual Reality to Control the Audio-visual Inputs During Ketamine/Esketamine Treatment

Yale University·interventional·Posted Nov 18, 2023·Updated Jun 29, 2026

In Brief

A clinical study evaluating Virtual reality for Depression. Completed, enrolled 7 participants across 1 site.

Detailed Summary

Investigators aim to examine the role of audiovisual inputs during treatment with ketamine/esketamine in affecting tolerability and effectiveness of treatment of depressive episodes, by providing patients with a relaxing environment using virtual reality goggles and noise cancelling headphones, and assessing whether these tools can improve the tolerability and effectiveness of treatment with ketamine/esketamine

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDepression
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedNov 18, 2023
Enrollment StartJul 11, 2024
Primary CompletionNov 27, 2024
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 2.6 years ago

Arms & Interventions

Treatment groupexperimental

This single arm will include all participants of the study, who will all receive the intervention

Device: Virtual reality

Interventions

Virtual realitydevice

Virtual reality gear and content will be used to affect and control the audiovisual perception of patients during a single treatment with ketamine/esketamine